Acumen Pharmaceuticals, Inc.
For the period ended Nov 6, 2025. Filed Nov 10, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 6, 2025 · Filed Nov 10, 2025
Use the contents to explore the available documents and sections.
ABOS$0.22+4.5%Stored close · as of Nov 6, 2026
Contents
(d).Exhibits
| Exhibit No. | Description |
| 99.1 | Press Release, dated November 10, 2025 |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.